MCE 的所有產品僅用作科學研究或藥證申報，我們不為任何個人用途提供產品和服務。

LY404039

CAS No. : 635318-11-5

MCE 國際站：LY404039

產品活性：LY404039 是一種有效的，選擇性的，具有口服活性的 mGluR2 和 mGluR3 激動劑，對重組人 mGluR2 和 mGluR3 的 K_i 分別為 149 nM 和 92 nM，比對其他受體/轉運蛋白的抑制性高 100 倍以上。LY404039 具有抗精神病和抗焦慮的作用。

研究領域：GPCR/G Protein  |  Neuronal Signaling

作用靶點：mGluR

In Vitro: LY404039 is a nanomolar potent agonist in rat neurons expressing native mGlu2/3 receptors (K_i = 88 nM).
?Functionally, LY404039 potently inhibits Forskolin-stimulated cAMP formation in cells expressing human mGlu2 (EC₅₀ = 23 nM) and mGlu3 receptors (EC₅₀ = 48 nM).
?Electrophysiological studies indicate that LY404039 suppresses electrically evoked excitatory activity in the striatum, and serotonin-induced L-glutamate release in the prefrontal cortex. LY404039 suppresses the frequency of 5-HT-induced excitatory postsynaptic currents (EPSCs) with an EC₅₀ of 82.3 nM and with a near maximal suppression of 85.6% at 1 μM.
?LY404039 inhibits the binding of the D2-specific antagonist, [3H]domperidone, to the human cloned D2 receptor with dissociation constants of 8.2 nM at D2High and 1640 nM at D2Low. Using rat striatal tissue, LY404039 has dissociation constants of 12.6 nM at D2High and 2100 nM at D2Low.

In Vivo: LY404039 attenuates amphetamine- and phencyclidine-induced hyperlocomotion (3-30 and 10 mg/kg, respectively). LY404039 (3-10 mg/kg) inhibits conditioned avoidance responding. LY404039 also reduces fear-potentiated startle in rats (3-30 μg/kg) and marble burying in mice (3-10 mg/kg), indicating anxiolytic-like effects. LY404039 (10 mg/kg) also increases dopamine and serotonin release/turnover in the prefrontal cortex.
?Following oral administration of LY404039 to fasted rats at doses of 1, 3, or 10 mg/kg, exposure increased proportionally with dose. LY404039 (10 mg/kg; p.o.) treatment shows the C_max is 1528.5 ng/mL and T_max is 2 hours in rats.

相關產品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Activators Library  |  L-Glutamine  |  LY341495  |  Xanthurenic acid  |  Ro 67-7476  |  DHPG  |  MPEP Hydrochloride  |  Eglumegad  |  MTEP hydrochloride  |  CHPG sodium salt  |  CTEP  |  (RS)-MCPG  |  JNJ16259685  |  LY367385 hydrochloride  |  LY2794193  |  LY379268  |  MMPIP hydrochloride  |  O-Phospho-L-serine  |  Dipraglurant  |  Mavoglurant  |  NPS 2390  |  RO0711401  |  Basimglurant  |  Foliglurax monohydrochloride  |  MSOP  |  CDPPB  |  JNJ-46778212

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種全球獨家化合物庫，我們致力于為全球科研客戶提供前沿最全的高品質小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領域；
•   產品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產品，廣泛應用于新藥研發(fā)、生命科學等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學分析檢測分析，藥物篩選等專業(yè)技術服務；
•   設有專業(yè)的實驗中心和嚴格的質控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告，確保產品的高純度、高品質；
•   產品的生物活性多經(jīng)各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥專利收錄了MCE客戶的科研成果；
•   專業(yè)團隊跟蹤最新的制藥及生命科學研究進展，為您提供全球最新的活性化合物；
•   與世界各大制藥公司及知名科研機構建立了長期的合作。